Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial

Veena Charu, Chandra P. Belani, Ahmad N. Gill, Mukesh Bhatt, Dianne Tomita, Greg Rossi, Ali Ben-Jacob

Research output: Contribution to journalArticle

29 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences